charcot-marie-tooth disease, axonal, type 2t: ['Charcot-Marie-Tooth disease type 2T (CMT2T) is a slowly progressive autosomal recessive sensorimotor peripheral neuropathy with onset in middle age (Higuchi et al., 2016).']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
311 |
4. Check minimum number of eventsNone |
311 |
5. Include endpointsNone |
311 |
6. Filter based on genotype QC (FinnGen only) |
311 |
Control definitions (FinnGen only)
- Control exclude
- G6_POLYNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G60
- Name in latin
- Neuropathia motoria et sensoria hereditaria
Similar endpoints
↥List of similar endpoints to
Hereditary motor and sensory neuropathy
based on the number of shared cases.
Similar with more cases:
- Polyneuropathies and other disorders of the peripheral nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2275 | 1031 | 1229 |
| Only index persons | 2023 | 939 | 1084 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 46.31 | 45.50 | 46.92 |
| Only index persons | 45.51 | 45.04 | 45.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 311 | 163 | 148 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.07 |
| Median age at first event (years) | 48.94 | 45.18 | 53.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 277
- Matched controls
- 2769
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
+∞
323.0
266
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
239.4
97.3
95
6
Z31.5
ICD-10 Finland
Genetic counselling
14.5
40.4
71
64
G60.9
ICD-10 Finland
Hereditary and idiopathic neuropathy, unspecified
+∞
27.6
26
*
N99
ICPC
Neurological disease other
46.6
27.5
33
8
33000
ICD-8 Finland
Hereditary neuromuscular disorders, Neuropathic muscular atrophy
+∞
22.2
21
*
G62.8
ICD-10 Finland
Other specified polyneuropathies
+∞
21.1
20
*
G60.8
ICD-10 Finland
Other hereditary and idiopathic neuropathies
+∞
20.0
19
*
G60
ICD-10 Finland
Hereditary and idiopathic neuropathy
+∞
15.8
15
*
R1250
NOMESCO Finland
Evaluation of functional capability
11.4
15.1
28
27
N28
ICPC
Limited function/disability (N)
14.5
14.5
24
18
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.9
13.0
44
103
N29
ICPC
Neurological sympt/complt other
13.2
12.9
22
18
3561A
ICD-9 Finland
Hereditary and idiopathic peripheral neuropathy, Peroneal muscular atrophy
+∞
12.6
12
*
L28
ICPC
Limited function/disability (L)
3.7
12.5
59
189
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.4
12.4
66
231
Q66.7
ICD-10 Finland
Pes cavus
67.9
11.7
13
*
NHL20
NOMESCO Finland
Myotomy or tenotomy of foot
+∞
11.5
11
*
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
125.0
11.5
12
*
SPAT1229
SPAT
Assessment of need for aid
4.8
11.5
39
92
N03AX12
ATC
gabapentin; oral
3.3
11.0
61
221
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.4
10.8
32
65
N94
ICPC
Peripheral neuritis/neuropathy
+∞
10.5
10
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
13.8
10.3
17
13
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.2
10.2
24
36
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
17.5
10.0
15
9
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.4
9.2
33
82
Z50.1
ICD-10 Finland
Other physical therapy
4.6
8.5
29
69
G61.0
ICD-10 Finland
Guillain-Barré syndrome
+∞
8.4
8
*
N03AX16
ATC
pregabalin; oral
2.4
8.1
79
395
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
7.9
45
165
G72.9
ICD-10 Finland
Myopathy, unspecified
46.3
7.8
9
*
Z82.0
ICD-10 Finland
Family history of epilepsy and other diseases of the nervous system
46.3
7.8
9
*
NHG20
NOMESCO Finland
Fusion of talocrural joint
25.8
7.6
10
*
R4110
NOMESCO Finland
Physiotherapy
2.3
7.5
82
434
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
9.8
7.4
14
15
35409
ICD-8 Finland
Polyneuritis and polyradiculitis, Unspecified
+∞
7.3
7
*
3569X
ICD-9 Finland
Hereditary and idiopathic peripheral neuropathy, Unspecified
+∞
7.3
7
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
+∞
7.3
7
*
L16
ICPC
Ankle symptom/complaint
3.1
7.2
40
143
N03AE01
ATC
clonazepam; systemic
4.4
6.9
24
59
L17
ICPC
Foot/toe symptom/complaint
2.2
6.9
83
455
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.9
6.8
27
75
M21.5
ICD-10 Finland
Acquired clawhand, clubhand, clawfoot and clubfoot
41.1
6.8
8
*
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
5.3
6.6
19
38
Q66.0
ICD-10 Finland
Talipes equinovarus
71.4
6.5
7
*
NXL00
NOMESCO Finland
Biopsy of muscle
71.4
6.5
7
*
L84
ICD-10 Finland
Corns and callosities
5.4
6.4
18
35
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
7.3
6.3
14
20
R4120
NOMESCO Finland
Occupational therapy
3.8
6.3
25
70
G60.3
ICD-10 Finland
Idiopathic progressive neuropathy
+∞
6.3
6
*
G64
ICD-10 Finland
Other disorders of peripheral nervous system
+∞
6.3
6
*
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
27.4
6.3
8
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
6.5
6.3
15
24
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.7
6.0
25
73
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004588) Protein electrophoresis panel - Serum or Plasma
46
138
3.74
13.48
2.0
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
158
925
2.44
13.36
2.1
1.9
pmol/l
102.4
97.0
0.68
84
495
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
12
10.36
10.50
1.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
84
3.85
9.64
1.9
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
84
3.85
9.64
1.9
2.1
g/l
3.1
4.0
4.16
23
65
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
84
3.85
9.64
1.9
2.1
g/l
6.5
7.4
3.80
23
70
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
124
732
2.15
9.45
2.4
2.1
u/l
241.4
218.5
0.19
116
691
(4027681)
10
15
6.85
6.35
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
23
81
2.99
5.21
2.0
2.2
ug/l
190.7
314.5
0.60
23
76
(3037522) Nuclear Ab [Titer] in Serum
62
347
1.98
5.08
1.4
1.4
titre
633.8
451.2
0.19
13
82
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
156
1161
1.69
4.91
5.7
6.3
mmol/l
1.2
1.2
0.00
137
992
(3019309) Folate [Moles/volume] in Red Blood Cells
72
429
1.88
4.90
1.8
1.6
nmol/l
1091.9
1157.5
0.23
55
321
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
144
1061
1.67
4.63
5.4
5.5
mmol/l
1.2
1.2
0.18
135
965
(3024561) Albumin [Mass/volume] in Serum or Plasma
138
1023
1.63
4.22
5.0
4.5
g/l
35.9
36.0
0.05
129
962
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
133
985
1.61
4.04
2.5
2.3
nmol/l
80.3
74.3
1.58
120
880
(3021960) Folate [Moles/volume] in Serum or Plasma
83
546
1.71
3.99
1.5
1.5
nmol/l
17.6
20.9
1.52
77
471
(3018418) pH of Serum or Plasma
100
695
1.65
3.90
2.7
3.7
ph
7.4
7.4
0.01
12
117
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
226
1913
1.66
3.86
7.6
7.4
u/l
79.8
78.4
0.22
209
1791
(3013707) Erythrocyte sedimentation rate by Westergren method
219
1847
1.63
3.72
4.3
4.0
mm/h
11.5
10.9
0.24
195
1708
(3044290) Cell count panel - Cerebral spinal fluid
14
45
3.21
3.70
1.4
2.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
144
2.20
3.67
1.2
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
30
3.76
3.67
1.5
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
18
5.11
3.39
1.6
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
124
933
1.55
3.38
6.3
7.6
inr
1.1
1.2
2.86
24
282
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
67
2.63
3.18
1.3
1.3
ug/g
277.7
292.4
0.10
12
35
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
29
3.53
3.07
1.3
1.4
nmol/l
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
158
1271
1.49
3.06
5.7
5.9
e9/l
0.5
0.6
0.61
134
1104
(3013115) Eosinophils [#/volume] in Blood
162
1310
1.49
3.05
6.0
6.3
e9/l
0.2
0.2
0.49
139
1164
(3006315) Basophils [#/volume] in Blood
158
1274
1.49
3.00
5.8
5.9
e9/l
0.0
0.0
0.20
134
1108
(3006653) Thiamine [Moles/volume] in Blood
6
10
6.09
2.71
1.0
1.0
nmol/l
136.7
129.5
—
6
10
(3026008) Bacteria identified in Urine by Culture
91
668
1.51
2.68
3.8
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
32
3.20
2.67
1.4
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
159
1306
1.44
2.63
6.0
6.0
e9/l
1.8
1.9
0.81
136
1159
(3022096) Basophils/100 leukocytes in Blood
143
1153
1.44
2.61
6.8
6.0
%
0.7
0.7
0.03
126
1087
(3019069) Monocytes/100 leukocytes in Blood
147
1192
1.44
2.60
7.1
6.3
%
8.3
8.7
0.58
132
1133
(3023410) Appearance of Cerebral spinal fluid
9
25
3.68
2.59
1.6
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
23
115
2.08
2.58
2.5
3.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
11
5.54
2.55
1.0
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
146
1186
1.44
2.54
6.6
6.0
%
2.8
2.9
0.11
131
1117
(3030467) Casts [#/volume] in Urine by Automated count
91
676
1.49
2.52
3.7
2.8
e6/l
0.2
0.4
1.62
76
510
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
60
408
1.58
2.48
2.8
2.6
e6/l
1.3
1.0
0.43
40
236
(3037756) Immunofixation for Serum or Plasma
13
51
2.62
2.47
1.0
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
102
780
1.46
2.43
2.3
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
44
278
1.68
2.42
2.2
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
253
2294
1.55
2.37
5.0
4.5
mu/l
1.7
2.4
0.68
231
2110
(3025941) Bacteria identified in Stool by Culture
26
142
1.91
2.31
1.2
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
97
741
1.45
2.30
3.8
3.0
e6/l
17.1
137.9
0.78
77
574
(3018010) Neutrophils/100 leukocytes in Blood
147
1211
1.41
2.29
6.3
5.9
%
58.7
56.5
1.31
133
1150
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
79
582
1.48
2.26
2.1
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
287
2693
1.85
2.25
10.5
10.0
u/l
26.9
26.7
0.05
282
2608
(3023520) Reticulocytes [#/volume] in Blood
33
197
1.76
2.23
1.7
2.7
e9/l
75.4
70.9
0.24
26
156
(3002030) Lymphocytes/100 leukocytes in Blood
148
1225
1.40
2.23
7.0
6.1
%
27.1
28.3
0.61
134
1157
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
81
2.16
2.17
1.4
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
51
346
1.57
2.13
2.6
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
25
3.26
2.11
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
25
3.26
2.11
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
10
5.06
2.08
1.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
194
1694
1.39
2.05
4.9
4.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
87
666
1.43
2.02
3.6
2.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
32
2.87
2.01
1.7
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
55
385
1.52
2.00
2.9
2.8
e6/l
1.9
2.4
0.20
36
217
(1761868) Lipid panel - Serum or Plasma
75
974
0.70
1.98
2.8
2.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
27
3.01
1.95
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
6
16
3.80
1.94
1.5
2.4
umol/l
240.8
76.6
—
6
9
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
212
1887
1.39
1.94
4.1
3.8
pmol/l
14.9
14.7
0.56
189
1721
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
58
2.30
1.93
1.3
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
154
1305
1.36
1.92
5.8
6.3
umol/l
10.4
11.3
0.58
147
1242
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
256
2358
1.48
1.91
12.4
12.2
ml/min/173m2
90.6
84.1
4.16
210
1927
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
140
1170
1.36
1.90
4.3
3.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
19
100
1.96
1.90
1.7
1.9
g/l
1.2
1.5
0.68
13
87
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
79
2.08
1.89
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
170
1465
1.35
1.89
7.6
9.4
e9/l
4.0
4.0
0.06
145
1285
(3021788) Differential panel - Synovial fluid
9
34
2.69
1.88
1.2
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
35
224
1.63
1.86
5.6
3.9
mmol/l
2.4
2.0
0.18
30
169
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
108
869
1.37
1.86
4.0
3.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
138
1.80
1.85
1.3
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
17
3.58
1.84
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
80
2.05
1.83
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
12
4.22
1.83
1.4
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
104
835
1.37
1.81
6.2
5.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
29
2.80
1.80
1.4
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
271
2533
1.54
1.80
16.5
13.1
mg/l
22.7
22.3
0.05
220
2009
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
13
3.89
1.72
1.4
5.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
13
3.89
1.72
2.0
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
433
1.45
1.71
1.3
1.3
iu/ml
48.2
38.3
0.13
19
146
(3013826) Glucose [Moles/volume] in Serum or Plasma
170
1479
1.33
1.71
5.0
4.4
mmol/l
6.6
6.6
0.07
163
1372
(3024354) Oxygen [Partial pressure] in Venous blood
31
197
1.64
1.70
4.6
3.3
kpa
4.6
4.6
0.03
31
192
(40761511) CBC panel - Blood by Automated count
283
2678
1.63
1.69
14.4
11.9
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
5
131
0.37
1.67
1.6
2.7
u/ml
15.4
38.8
—
5
124
(3001122) Ferritin [Mass/volume] in Serum or Plasma
131
1106
1.32
1.59
2.7
2.5
ug/l
102.2
112.9
0.22
121
1018
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
67
511
1.40
1.57
1.5
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
538
1.39
1.57
1.5
1.8
mg/l
0.7
1.2
2.59
55
422
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
78
1.97
1.57
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
31
202
1.59
1.56
6.2
6.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
68
521
1.39
1.55
1.5
1.4
g/l
2.2
2.4
0.37
43
313
(3019225) pH of Specimen
33
219
1.57
1.54
3.6
3.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
43
0.00
1.53
0.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
296
2844
1.85
1.53
22.2
19.1
pg
30.1
30.3
1.64
296
2811
(3024731) MCV [Entitic volume]
296
2844
1.85
1.53
22.2
19.1
fl
90.4
90.8
0.84
296
2811
(4024509)
5
15
3.37
1.53
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
80
632
1.36
1.52
3.8
4.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
296
2845
1.84
1.51
22.3
19.2
e12/l
4.5
4.5
0.28
288
2771
(3018095) Leukocytes [#/volume] in Urine
106
874
1.32
1.51
4.5
3.5
e6/l
70.5
66.1
0.05
83
626
(3010813) Leukocytes [#/volume] in Blood
296
2846
1.83
1.49
22.4
19.2
e9/l
6.6
6.6
0.14
289
2772
(40760888) Immunoglobulin light chains.free panel - Serum
10
45
2.26
1.48
1.5
3.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
66
508
1.38
1.47
3.3
2.3
e6/l
9.6
6.5
0.42
55
446
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
34
230
1.54
1.47
2.0
2.5
u/l
28.8
36.4
0.88
28
200
(3000963) Hemoglobin [Mass/volume] in Blood
296
2848
1.82
1.46
22.5
19.3
g/l
134.8
136.7
1.47
296
2810
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
307
0.59
1.40
1.4
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
39
275
1.48
1.39
2.8
2.6
%
1.9
1.8
0.25
31
246
(3000494) Fungus identified in Specimen by Culture
41
293
1.46
1.37
1.7
1.4
—
—
—
0
0
(4306422)
0
38
0.00
1.35
0.0
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
32
219
1.51
1.32
2.8
1.9
nmol/l
347.5
359.6
0.13
32
204
(3013512) EKG study
84
682
1.32
1.32
4.3
3.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
38
270
1.46
1.32
1.5
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
24
2.53
1.31
1.2
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
24
2.53
1.31
1.0
1.2
—
68.0
—
0
5
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
256
2407
1.36
1.26
4.4
4.3
mmol/l
5.9
5.9
0.17
239
2217
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
25
2.43
1.25
1.5
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
37
265
1.45
1.24
3.9
4.0
u/l
256.3
235.3
0.41
32
254
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
414
1.37
1.24
1.3
1.3
u/ml
2.3
13.4
2.05
19
164
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
342
0.65
1.21
1.7
2.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
27
182
1.53
1.20
2.4
2.3
e9/l
4.0
4.1
0.06
19
143
(40758558) Short blood count panel - Blood
78
636
1.30
1.18
5.2
7.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
374
1.37
1.16
2.1
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
253
1.43
1.13
7.7
7.2
mmol/l
2.6
1.2
0.73
28
211
(3009261) Glucose [Presence] in Urine by Test strip
140
1234
1.24
1.12
4.2
3.5
estimate
0.0
0.0
0.00
23
227
(40768804) Tissue Pathology biopsy report
114
982
1.25
1.11
1.8
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
14
81
1.76
1.11
2.4
3.8
g/l
0.2
0.2
—
5
34
(3019150) Specific gravity of Urine by Refractometry
68
550
1.30
1.10
4.5
3.5
kg/l
1.0
1.0
0.72
16
71
(3002256) Pathology report gross observation
39
290
1.39
1.08
1.4
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
442
1.33
1.07
3.9
3.9
ng/l
107.8
155.6
0.30
42
337
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
71
580
1.29
1.06
1.3
1.3
u/ml
0.6
1.5
1.71
18
157
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
79
655
1.28
1.06
3.0
3.2
ng/l
1295.5
1091.3
0.16
60
547
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
41
310
1.37
1.04
2.8
2.7
umol/l
8.0
9.2
0.11
36
274
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
34
2.08
1.03
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
34
2.08
1.03
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
58
463
1.31
1.03
1.5
1.7
pmol/l
456.0
9975499.5
0.50
50
401
(3035350) Ketones [Presence] in Urine by Test strip
137
1213
1.23
1.03
4.2
3.4
estimate
0.0
0.0
0.00
22
241
(3015377) Calcium [Moles/volume] in Serum or Plasma
90
761
1.26
1.02
3.9
3.3
mmol/l
2.4
2.3
0.16
78
679
(4010399)
26
181
1.48
1.02
1.5
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
71
584
1.28
1.01
2.6
2.0
mg/l
3.2
3.1
0.15
61
502
(3021601) Nitrite [Presence] in Urine by Test strip
137
1215
1.23
1.01
6.1
4.7
estimate
0.0
0.0
0.00
22
238
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
35
2.02
1.00
1.0
2.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
100
1.63
0.98
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
30
0.00
0.98
0.0
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
404
1.31
0.96
3.3
2.7
mmol/l
2.4
2.4
0.03
42
359
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
261
2487
1.31
0.96
4.2
4.4
mmol/l
4.8
4.7
1.27
248
2328
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
253
1.39
0.95
1.9
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
51
1.79
0.95
1.8
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
128
1136
1.22
0.92
9.2
9.6
e9/l
0.0
0.0
0.56
105
928
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
299
1.35
0.92
4.7
4.5
%
29.6
32.1
1.03
32
198
(3028626) Oxygen [Partial pressure] in Capillary blood
11
63
1.77
0.91
3.1
2.4
kpa
8.2
8.5
0.23
11
58
(3026782) Osmolality of Urine
59
481
1.28
0.90
3.4
2.6
mosm/kgh2o
555.6
568.8
0.15
51
412
(36660697) Celiac disease serology panel - Serum
29
212
1.41
0.90
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
66
546
1.27
0.90
3.7
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
42
327
1.33
0.90
2.2
2.2
%
20.2
23.2
1.07
36
282
(3004809) Band form neutrophils/100 leukocytes in Blood
6
29
2.09
0.90
8.7
3.1
%
0.8
1.3
—
6
24
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
30
2.02
0.87
5.8
3.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
261
0.67
0.87
1.3
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
44
1.84
0.86
1.4
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
45
1.80
0.85
1.6
2.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.85
1.3
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
121
1.52
0.84
4.9
3.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
248
2360
1.25
0.84
15.1
13.8
%
39.4
40.6
1.04
177
1802
(3052851) Hemolysis interference index of Serum or Plasma
12
73
1.67
0.83
1.7
3.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
264
2532
1.28
0.82
4.8
4.8
mmol/l
2.9
2.8
0.94
246
2352
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
47
1.72
0.81
1.5
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.3
1.5
—
—
—
0
0
(4281824)
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
37
290
1.31
0.77
6.6
6.6
mmol/l
102.6
104.2
1.08
37
282
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
13
83
1.59
0.76
1.2
1.5
miu/ml
214.8
256.9
—
5
42
(3044889) 12 lead EKG panel
185
1721
1.19
0.75
3.5
3.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
24
2.10
0.75
1.2
2.9
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.0
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
56
1.62
0.73
1.2
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.0
1.2
—
—
—
0
0
(4062490)
5
25
2.02
0.73
1.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
25
2.02
0.73
8.4
3.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.0
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
60
1.69
0.73
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
258
2478
1.24
0.72
4.2
4.3
mmol/l
1.5
1.5
0.09
241
2306
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
58
1.57
0.70
1.2
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
69
1.62
0.69
5.1
2.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
69
1.62
0.69
1.0
1.1
—
1.0
—
0
8
(3021901) Oxygen saturation in Capillary blood
7
43
1.64
0.67
3.4
2.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
70
1.59
0.66
5.6
4.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
11
70
1.59
0.66
1.2
1.3
u/ml
2.3
8.0
—
5
14
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
44
1.60
0.65
1.1
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
268
0.73
0.65
2.0
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
250
2401
1.21
0.65
3.8
3.9
mmol/l
1.3
1.3
0.10
233
2225
(21494755) Public health laboratory ask at order entry panel
22
288
0.75
0.62
1.5
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
91
809
1.18
0.62
3.6
2.5
u/l
57.2
58.2
0.10
83
750
(3017181) Myelocytes/100 leukocytes in Blood
27
210
1.31
0.61
5.3
4.4
%
0.7
1.0
—
9
65
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
51
1.58
0.61
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
239
2291
1.19
0.60
6.3
5.5
mmol/mol
39.3
39.6
0.14
225
2149
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
1.0
—
0
20
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
20.9
—
1377.8
—
0
21
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
64
1.58
0.59
1.5
3.1
—
1.2
—
0
6
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
89
1.48
0.59
1.9
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
257
1.27
0.58
2.0
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
295
1.25
0.56
6.1
7.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
187
1.31
0.54
3.1
3.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.5
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
61
1.49
0.54
3.7
2.1
mmol/l
28.4
24.6
—
9
51
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
39
1.55
0.53
1.3
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
186
1759
1.14
0.53
3.3
3.1
u/l
47.0
47.6
0.04
176
1663
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
103
936
1.15
0.53
3.6
3.6
ng/l
37.8
42.3
0.13
79
616
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
144
1.34
0.52
1.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
40
1.51
0.52
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
40
1.51
0.52
1.2
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
14
101
1.40
0.50
6.7
5.5
%
1.3
0.9
0.36
14
96
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
190
1.29
0.49
1.7
2.7
ml/min/173m2
68.4
67.9
—
7
77
(3000492) Spirometry study
31
254
1.24
0.49
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
45
1.57
0.49
1.3
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
45
1.57
0.49
1.1
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
23
182
1.28
0.48
5.9
4.7
%
0.0
0.2
—
8
49
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
94
1.40
0.46
2.2
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
120
0.66
0.46
1.1
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
82
740
1.15
0.46
3.3
3.0
mmol/l
7.2
8.4
1.34
71
619
(3003694) ABO and Rh group [Type] in Blood
64
718
0.86
0.46
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
50
1.41
0.45
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
157
1.29
0.44
7.1
4.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
72
646
1.15
0.44
2.4
2.6
umol/l
7152.7
5486.0
0.09
63
563
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
14
104
1.36
0.44
5.9
5.4
%
1.3
1.5
0.64
14
98
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.6
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
306
1.20
0.42
1.5
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
24
292
0.81
0.41
1.5
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
1.8
1.4
nmol/l
0.1
0.4
—
5
25
(3019977) pH of Arterial blood
0
15
0.00
0.41
0.0
7.5
—
7.4
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
17
132
1.30
0.41
7.8
8.4
%
94.4
93.7
0.30
17
132
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
18
0.00
0.40
0.0
1.4
—
176.9
—
0
18
(3023183) Ammonium ion [Moles/volume] in Plasma
8
61
1.32
0.40
3.6
3.5
umol/l
29.9
32.3
—
8
52
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
53
469
1.16
0.39
2.8
3.0
ug/l
0.8
0.7
0.06
38
288
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
35
1.44
0.39
1.0
1.1
—
1.1
—
0
15
(1617658) Protocol used for examination of sentinel lymph nodes
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
66
1.37
0.38
1.4
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
38
328
1.18
0.38
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
56
500
1.15
0.37
1.5
1.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
37
1.36
0.37
3.0
3.9
%
64.7
57.8
—
5
37
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
665
1.13
0.36
1.8
1.7
mmol/l
1.4
1.4
0.30
59
570
(3020682) Albumin/Creatinine [Ratio] in Urine
77
704
1.12
0.36
3.8
3.9
mg/mmol
18.5
10.1
0.25
52
442
(3012516) Albumin [Mass/volume] in Urine
73
666
1.13
0.35
3.5
3.1
mg/l
85.9
263.0
0.64
49
431
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
22
262
0.83
0.32
3.2
4.5
ug/l
9.8
23.9
0.39
17
219
(3003327) Ova and parasites identified in Stool by Light microscopy
11
83
1.34
0.32
1.6
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
110
1.29
0.32
1.6
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
87
807
1.11
0.32
4.5
4.8
ug/l
2.2
2.6
0.34
77
732
(3021440) Promyelocytes/100 leukocytes in Blood
23
193
1.21
0.32
6.0
4.6
%
0.0
0.2
—
7
57
(3001019) Free T4 and TSH panel - Serum or Plasma
10
131
0.76
0.31
1.2
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
174
0.80
0.30
1.4
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
62
569
1.11
0.28
4.4
4.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
63
1.28
0.28
1.9
1.9
—
—
—
0
0
(1002224) Polysomnography panel
9
116
0.77
0.28
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
196
1.19
0.28
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
120
0.74
0.28
1.4
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
102
962
1.09
0.27
4.6
3.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
178
1.19
0.27
1.9
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
66
1.22
0.27
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
75
0.66
0.26
1.2
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
181
0.82
0.26
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
178
1720
1.08
0.26
2.8
3.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
17
142
1.21
0.25
4.8
6.9
mmol/l
24.6
25.0
0.21
17
142
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
115
1.23
0.24
10.1
8.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
115
1.23
0.24
5.1
3.3
%
1.4
1.4
0.01
14
115
(3029937) Albumin [Presence] in Urine by Test strip
62
667
0.91
0.23
4.4
3.7
estimate
0.0
0.0
0.68
20
233
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
38
1.32
0.23
2.0
3.4
%
62.6
59.8
—
5
38
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
38
1.32
0.23
2.2
3.3
e9/l
5.0
4.9
—
5
38
(4035726)
23
200
1.16
0.23
1.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
40
1.25
0.22
1.4
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
69
645
1.09
0.22
3.8
4.3
%
23.0
21.1
0.48
32
295
(3022621) pH of Urine by Test strip
14
167
0.83
0.22
2.6
2.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.6
1.4
—
—
—
0
0
(4034850)
8
101
0.79
0.21
17.6
9.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
102
0.78
0.21
1.4
1.7
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.9
—
6.5
—
0
11
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
103
0.77
0.21
3.7
3.6
u/ml
24.8
590.2
—
8
89
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
48
1.25
0.20
2.8
2.4
kpa
4.5
4.9
—
6
48
(3027315) Oxygen [Partial pressure] in Blood
6
48
1.25
0.20
2.8
2.4
kpa
8.5
8.7
—
6
48
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
90
1.23
0.19
1.3
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
89
848
1.07
0.18
3.9
3.4
u/l
36.0
32.5
0.44
82
807
(3003338) MCHC [Mass/volume]
226
2219
1.07
0.17
19.0
16.6
g/l
332.6
333.1
0.33
226
2208
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
82
1.23
0.17
1.3
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
38
350
1.10
0.17
2.4
2.2
ug/g
125.6
109.6
0.19
29
281
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
70
0.71
0.17
1.8
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
43
400
1.09
0.16
1.4
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
123
1.14
0.12
2.3
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
382
0.93
0.10
1.7
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
223
1.08
0.09
3.8
3.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
48
1.04
0.09
2.0
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
55
1.09
0.09
1.2
1.3
nmol/l
0.7
0.8
—
6
46
(3028707) Methadone [Presence] in Urine by Screen method
6
55
1.09
0.09
1.3
1.6
—
—
—
0
0
(3010421) pH of Blood
6
55
1.09
0.09
2.8
2.3
ph
7.4
7.4
—
6
48
(3030981) Hyaline casts [#/volume] in Urine by Automated count
15
136
1.11
0.08
3.2
2.6
e6/l
0.2
0.1
0.35
15
131
(3039000) Anion gap in Blood
6
56
1.07
0.08
10.7
6.9
mmol/l
11.5
11.2
—
6
51
(3018572) Chloride [Moles/volume] in Blood
6
56
1.07
0.08
10.7
6.9
mmol/l
105.7
105.0
—
6
51
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
144
0.90
0.08
1.3
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
64
0.78
0.08
1.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
64
1.10
0.08
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
67
1.05
0.08
1.3
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
4.8
4.6
mg/l
1.4
1.5
—
6
69
(3002179) Metamyelocytes/100 leukocytes in Blood
20
186
1.08
0.07
4.9
4.3
%
0.0
0.4
—
5
43
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
147
1.09
0.07
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
85
1.06
0.07
1.6
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
68
699
0.97
0.06
4.5
3.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
120
0.91
0.05
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
119
0.92
0.04
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
119
0.92
0.04
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
21
201
1.05
0.03
3.4
3.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
23
221
1.04
0.03
9.2
7.7
g/l
120.9
123.2
0.16
23
213
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
262
1.03
0.02
1.4
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
133
1.06
0.01
1.9
1.6
—
—
—
0
0
(3020891) Body temperature
9
89
1.01
0.00
11.7
4.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
69
1.01
0.00
1.7
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
64
0.94
0.00
1.3
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
41.2
—
0
5
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
5.2
—
25.0
—
0
6
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4094501)
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
34.6
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
92
0.98
0.00
2.1
2.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
67
0.89
0.00
3.0
1.7
pmol/l
159.0
258.8
—
6
62
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
4.0
—
0
6
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
54
0.92
0.00
1.6
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
110
1.00
0.00
1.4
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
57.3
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
85
0.94
0.00
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
79
1.01
0.00
1.0
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
76
0.92
0.00
1.3
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
49
1.02
0.00
3.0
4.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
49
1.02
0.00
1.4
1.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HEREMOSEN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HEREMOSEN | 1.393 [1.1, 1.76] | 0.005 |
| Birth year | 0.994 [0.99, 1.0] | 0.177 |
During the follow-up period (1.1.1998 — 31.12.2019), 103 out of 825 females with G6_HEREMOSEN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HEREMOSEN | 1.226 [1.01, 1.49] | 0.039 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 170 out of 979 males with G6_HEREMOSEN died.
Mortality risk
Mortality risk for people of age
years, who have G6_HEREMOSEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.144% | 0.227% |
| 5 | 0.742% | 1.433% |
| 10 | 1.911% | 3.496% |
| 15 | 3.983% | 6.669% |
| 20 | 6.914% | 11.055% |
Relationships between endpoints
↥Index endpoint: G6_HEREMOSEN – Hereditary motor and sensory neuropathy
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data